Intervention Review

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

  1. Elvira C van Dalen1,*,
  2. Helena JH van der Pal2,
  3. Huib N Caron1,
  4. Leontien CM Kremer1

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 11 MAY 2009

DOI: 10.1002/14651858.CD005008.pub3


How to Cite

van Dalen EC, van der Pal HJH, Caron HN, Kremer LCM. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD005008. DOI: 10.1002/14651858.CD005008.pub3.

Author Information

  1. 1

    Emma Children's Hospital/Academic Medical Center, Department of Paediatric Oncology, Amsterdam, Netherlands

  2. 2

    Academic Medical Center, room F4-150, Medical Oncology, Amsterdam, Netherlands

*Elvira C van Dalen, Department of Paediatric Oncology, Emma Children's Hospital/Academic Medical Center, PO Box 22660 (room TKsO-247), Amsterdam, 1100 DD, Netherlands. e.c.vandalen@amc.uva.nl.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.